Weak anti-SARS-CoV-2 antibody response is associated with mortality in a Swedish cohort of COVID-19 patients in critical care

Samankaltaisia teoksia

• The impact of viremia on organ failure, biomarkers and mortality in a Swedish cohort of critically ill COVID-19 patients
  Tekijä: Järhult, Josef D., et al.
  Julkaistu: (2021)
• Presence of SARS-CoV-2 in urine is rare and not associated with acute kidney injury in critically ill COVID-19 patients
  Tekijä: Frithiof, Robert, et al.
  Julkaistu: (2020)
• Blood type A associates with critical COVID-19 and death in a Swedish cohort
  Tekijä: Hultström, Michael, et al.
  Julkaistu: (2020)
• The swedish covid‐19 intensive care cohort: Risk factors of ICU admission and ICU mortality
  Tekijä: Ahlström, Björn, et al.
  Julkaistu: (2021)
• Increased levels of plasma cytokines and correlations to organ failure and 30-day mortality in critically ill Covid-19 patients
  Tekijä: Bülow Anderberg, Sara, et al.
  Julkaistu: (2021)